UnitedHealth
Institution - official statements with no named speaker · USA
Track record: No forecast checked yet (14 not due, 16 being checked).
30forecasts & commitments on the record
63%can be checked as stated
32average ambiguity (0-100)
0goalpost moves recorded
0confirmed U-turns
Timeline
came true partly did not not due / being checked / too vague
Calibration score: shown after 10 checked forecasts with a stated likelihood (now 0).
How they speak about the future: based on data 28, stated on authority 2.
Kinds of claim: forecast 29, commitment 1. · Download this report card as a picture
In the nine words
πρόγνωσιςInference from evidence27 · 90%μαντείαInspired knowledge1 · 3%χρησμοδοσίαInstitutional delivery1 · 3%πρόβλεψιςSeeing the signs1 · 3%
How to read this
Each box is one sentence a public figure or institution said about the future, word for word, with a link to the official text. Can be checked means it names what will happen, by when, and how likely - so it can be compared with official figures later. Too vague to check means it does not. Ambiguity (0-100) is how many different ways the sentence can be read. When the date passes, the forecast is compared with official data and marked came true, partly or did not come true. Labels judge the sentence, never the person. Full guide and glossary.On the record (30)
For the projected year ended December 31, 2025 intangible amortization per share is ~$1.75, with tax effects of ~$(0.40).
For the projected year ended December 31, 2025 intangible amortization is ~$1,625, with tax effects of ~$(400).
•Full year 2025 revenues for UnitedHealthcare are expected to range from $344.0 billion to $345.5 billion, growth of more than 15% over 2024.
The full year 2025 tax rate is now expected to be ~18.5%, affected by the revised earnings outlook while the expected tax benefit levels remain steady.
On May 13, 2025, UnitedHealth Group suspended its 2025 outlook.
The pricing and benefit designs for 2026 anticipate these trends to continue to accelerate meaningfully to nearly 10%.
The company expects to return to earnings growth in 2026.
“As we strengthen operating disciplines, positioning us for growth in 2026 and beyond, the people at UnitedHealth Group will continue to support the millions of patients, physicians and customers who rely on us, guided by a culture of service and longstanding values.”
December 31,Projected Year Ended December 31,
At the end of 2024, Optum Health served 4.7 million people with value-base care and expects to grow to serve an additional 650,000 patients in 2025.
The business portfolio refinement, including strategic transactions, will enhance growth opportunities and contributed about 80 basis points, nearly half at Optum Health with the remainder split between UnitedHealthcare and Optum Insight.
•UnitedHealthcare serves 9.4 million seniors and people with complex needs and the company’s 2025 Medicare Advantage plans will reach 96% of eligible Medicare beneficiaries.
These amounts are not included within the adjustment to net earnings for the three months ended March 31, 2024 and the projected year ended December 31, 2024.
December 31,Year Ended December 31,Projected Year Ended
The combination with Change Healthcare was completed at the beginning of the fourth quarter 2022 and will accelerate efforts to better connect and simplify the core clinical, administrative and payment processes health care providers and payers depend on to serve patients.
Medicaid contract awards in Hawaii and Ohio, as well as a strong pipeline of potential new and renewing awards during the remainder of 2021; and further expansion of innovative commercial benefit products and capabilities such as our care provider-aligned and consumer-centric products, and continued outlook for strong specialty benefits growth.
UnitedHealth Group is focused on helping people access the care they need, including vaccinations, and expects a continued rise in provision of care in the second half of this year.
As previously announced, the OptumInsight and Change Healthcare (NASDAQ: CHNG) combination is expected to close during the second half 2021.
•UnitedHealthcare growth highlights for 2021 include: serving an expected up to 1.5 million more people in total, with growth in Individual and Group Medicare Advantage and Dual Special Needs Plans approaching 900,000 people;
•UnitedHealthcare growth highlights include strong positioning in Medicare Advantage in 2021; expected Medicaid membership gains in 2021 through entry into Kentucky, Indiana and North Carolina and expansion in Nebraska, along with a strong proposal pipeline for existing and new states; continued growth in dual special needs plans; commercial market expansion in specialty benefits and new provider-led benefit plans.
First quarter 2020 earnings from operations of $2.9 billion were roughly in line with last year, as expected, and were impacted by the extra calendar days in this year’s quarter.
OptumRx fulfilled 339 million adjusted scripts in first quarter 2019, which is growth of 2.1 percent over the prior year, consistent with full year 2019 growth projections.
As we look ahead, we will drive our growth on the strength of practical innovations that anticipate and respond to increasing consumer expectations and clear social needs,” said David S.
UnitedHealthcare Employer & Individual first quarter 2018 revenues of $13.4 billion increased $675 million year-over-year, due to growth in people served over the past 12 months, increases in rates to cover expected medical cost trends and the resumption of the health insurance tax.
Fourth quarter 2017 earnings from operations of $1.8 billion were ahead of the Company’s outlook, due to strong business growth and increased reserve development.
“In 2017 we have been fortunate to serve the health care needs of more customers and consumers in increasingly diverse ways, and we expect the opportunities to do so will grow even further in 2018, 2019 and beyond,” said David S.
The full year 2017 tax rate is now estimated to be 32.5 percent, down from a previous outlook of 34 percent to 34.5 percent.
“Our growth indicators are positive as we conclude 2016, and we expect to be well positioned in 2017 to better serve consumers and deliver more value to the health system overall,” said Stephen J.
The Company expects this ratio to decrease during the second half of 2016 as debt levels are reduced.
The Company affirmed its 2016 financial outlook, including estimated revenues of more than $180 billion, rising net earnings growth to a range of $7.60 to $7.80 in adjusted earnings per share, and strong cash flows from operations in the range of $9.5 billion to $10 billion.